{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:46:30Z","timestamp":1793195190889,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Hellenic Department of Health","award":["51657"],"award-info":[{"award-number":["51657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00277-019-03615-z","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T11:12:34Z","timestamp":1548414754000},"page":"775-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antibody persistence 5\u00a0years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with \u03b2-thalassemia: assessing the need for booster"],"prefix":"10.1007","volume":"98","author":[{"given":"Ioanna","family":"Papadatou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-2488","authenticated-orcid":false,"given":"Theano","family":"Lagousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Kattamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"3615_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1128\/CMR.00048-09","volume":"23","author":"S Ram","year":"2010","unstructured":"Ram S, Lewis LA, Rice PA (2010) Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 23:740\u2013780","journal-title":"Clin Microbiol Rev"},{"key":"3615_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1600-0609.2011.01582.x","volume":"86","author":"V Ladis","year":"2011","unstructured":"Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86:332\u2013338","journal-title":"Eur J Haematol"},{"key":"3615_CR3","first-page":"816","volume":"61","author":"CDC","year":"2012","unstructured":"CDC (2012) Use of 13-valent pneumococcal conjugate vaccine and 23- valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 61:816\u2013819","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3615_CR4","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.4049\/jimmunol.181.5.3684","volume":"181","author":"H Wasserstrom","year":"2008","unstructured":"Wasserstrom H, Bussel J, Lim LC-L, Cunningham-Rundles C (2008) Memory B cells and pneumococcal antibody after splenectomy. J Immunol 181:3684\u20133689","journal-title":"J Immunol"},{"key":"3615_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/cid\/ciu409","volume":"59","author":"I Papadatou","year":"2014","unstructured":"Papadatou I, Piperi C, Alexandraki K, Kattamis A, Theodoridou M, Spoulou V (2014) Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with \u03b2-thalassemia previously immunized with 23- valent pneumococcal polysaccharide vaccine. Clin Infect Dis 59:862\u2013865","journal-title":"Clin Infect Dis"},{"issue":"32","key":"3615_CR6","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1016\/j.vaccine.2015.06.100","volume":"33","author":"I Papadatou","year":"2015","unstructured":"Papadatou I, Orthopoulos G, Theodoridou M, Spoulou V (2015) Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in asplenic patients with \u03b2-thalassemia major. Vaccine 33(32):3779\u20133783","journal-title":"Vaccine"},{"key":"3615_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1086\/509619","volume":"194","author":"C Auckland","year":"2006","unstructured":"Auckland C, Gray S, Borrow R, Andrews N, Goldblatt D, Ramsay M, Miller E (2006) Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis 194:1745\u20131752","journal-title":"J Infect Dis"},{"key":"3615_CR8","first-page":"182","volume":"43","author":"N Bisharat","year":"2001","unstructured":"Bisharat N, Omari H, Lavi I, Raz R (2001) Risk of infection and death among post-splenectomy patients. J Inf Secur 43:182\u2013186","journal-title":"J Inf Secur"},{"key":"3615_CR9","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1016\/j.vaccine.2009.03.017","volume":"27","author":"J Poolman","year":"2009","unstructured":"Poolman J, Kriz P, Feron C, Di-Paolo E, Henckaerts I et al (2009) Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics. Vaccine 27:3213\u20133222","journal-title":"Vaccine"},{"key":"3615_CR10","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","volume":"25","author":"SA Madhi","year":"2007","unstructured":"Madhi SA, Adrian P, Kuwanda L, Jassat W, Jones S, Little T, Soininen A, Cutland C, Klugman KP (2007) Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 25:2451\u20132457","journal-title":"Vaccine"},{"key":"3615_CR11","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","volume":"180","author":"G Blanchard Rohner","year":"2008","unstructured":"Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM, Borkowski A, Ceddia F, Borrow R, Siegrist CA, Pollard AJ (2008) The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response. J Immunol 180:2165\u20132173","journal-title":"J Immunol"},{"issue":"12","key":"3615_CR12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.vaccine.2013.11.106","volume":"32","author":"CD Liakou","year":"2014","unstructured":"Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI (2014) Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 32(12):1394\u20131397","journal-title":"Vaccine"},{"key":"3615_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","volume":"411","author":"IJ Amanna","year":"2011","unstructured":"Amanna IJ, Slifka MK (2011) Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411:206\u2013215","journal-title":"Virology"},{"issue":"5","key":"3615_CR14","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1097\/INF.0000000000001497","volume":"36","author":"J Tr\u00fcck","year":"2017","unstructured":"Tr\u00fcck J, Mitchell R, Jawad S, Clutterbuck EA, Snape MD, Kelly DF, Voysey M, Pollard AJ (2017) Divergent memory B-cell responses in a mixed infant pneumococcal conjugate vaccine schedule. Pediatr Infect Dis J 36(5):e130\u2013e135","journal-title":"Pediatr Infect Dis J"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03615-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T19:16:34Z","timestamp":1579893394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3615"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03615-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}